Home Why NAFDAC recalled Dove Beauty Cream Bar Soap

Why NAFDAC recalled Dove Beauty Cream Bar Soap

Share
Share

By Chioma Obinagwam

The National Agency for Food and Drug Administration and Control (NAFDAC) is alerting the public about the recall of Dove Beauty Cream Bar Soap (100g) with batch number 81832M 08, produced in Germany, due to chemical impurity.

Confiance News gathered from on Friday.

“The product does not comply with the Cosmetic Products Regulation as it is said to contain Butylphenyl Methylpropional (BMHCA) which is prohibited in cosmetic products due to its risk of harming the reproductive system, causing harm to the health of an unborn child and may cause skin sensitization. As a result, a ban on the marketing of the product has been placed by some regulatory and public authorities, in the EU,” NAFDAC said.

Here are details of the product:

The details of the product are as follows.

Product Name: Dove Beauty Cream Bar Soap

Product Brand: Dove

Country of Manufacture: Germany

Bar Code Number: 8000700000005

Category: Cosmetics

Product Photo:

Photo credit: NAFDAC

Confiance News learnt that other Dove cosmetic products recalled/banned in other countries due to presence of Butylphenyl Methylpropional are as follows; See link:

https://nafdac.gov.ng/public-alert-no-035-2024-alert-on-the-recall-of-dove-beauty-cream-bar-soap-due-to-butyphenyl-methylpropional-bmhca-content/

Importation of soaps, it says, is prohibited in Nigeria as per the restricted and import prohibition list. Beyond the import restrictions soaps and cosmetics are parts of the items ineligible for foreign exchange to import in Nigeria.

“These products are also not available in the NAFDAC database. Importers, distributors, retailers and consumers are advised to exercise caution and vigilance within the supply chain to avoid the importation, distribution, sale and use of the above-mentioned products. Members of the public in possession of the product should discontinue the sale or use and submit stock to the nearest NAFDAC office.

“Healthcare professionals and consumers are encouraged to report adverse events experienced with the use of regulated products to the nearest NAFDAC office, via pharmacovigilance@nafdac.gov.ng, E-reporting platforms available at www.nafdac.gov.ng,” it advised.

Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Articles
Business & Economy

‎𝗖𝗕𝗡 𝗵𝗼𝗹𝗱𝘀 𝗕𝗲𝗶𝗷𝗶𝗻𝗴 𝗿𝗼𝘂𝗻𝗱𝘁𝗮𝗯𝗹𝗲 𝘁𝗼 𝘀𝘁𝗿𝗲𝗻𝗴𝘁𝗵𝗲𝗻 𝗡𝗶𝗴𝗲𝗿𝗶𝗮-𝗖𝗵𝗶𝗻𝗮 𝗳𝗶𝗻𝗮𝗻𝗰𝗶𝗮𝗹 𝗰𝗼𝗿𝗿𝗶𝗱𝗼𝗿‎

‎𝗖𝗮𝗿𝗱𝗼𝘀𝗼 𝘀𝗲𝗲𝗸𝘀 𝗳𝗶𝗿𝘀𝘁𝗵𝗮𝗻𝗱 𝗶𝗻𝗽𝘂𝘁 𝗼𝗻 𝗰𝗿𝗼𝘀𝘀-𝗯𝗼𝗿𝗱𝗲𝗿 𝗽𝗮𝘆𝗺𝗲𝗻𝘁𝘀 𝗮𝗻𝗱 𝗯𝗮𝗻𝗸𝗶𝗻𝗴 𝗹𝗶𝗻𝗸𝘀‎‎• ‎The Central...

Business & Economy

‎Dangote acquires 25 per cent stake in Kenya pipeline network‎

• ‎Aliko Dangote reveals a 25 per cent stake in a Kenya...

Business & Economy

‎FMDQ records ₦551.23 trillion turnover in nine months

· ‎FMDQ Exchange turnover reached ₦551.23 trillion between January and September 2026,...

Technology 

‎𝗜𝗫𝗣𝗡 𝘁𝗼 𝗵𝗼𝗻𝗼𝘂𝗿 𝗜𝗧𝗥𝗲𝗮𝗹𝗺𝘀 𝗳𝗼𝘂𝗻𝗱𝗲𝗿 𝗥𝗲𝗺𝗺𝘆 𝗡𝘄𝗲𝗸𝗲 𝗮𝘁 𝟮𝟬𝘁𝗵 𝗮𝗻𝗻𝗶𝘃𝗲𝗿𝘀𝗮𝗿𝘆‎

‎𝗚𝗮𝗹𝗮 𝘁𝗼 𝗺𝗮𝗿𝗸 𝘁𝘄𝗼 𝗱𝗲𝗰𝗮𝗱𝗲𝘀 𝗼𝗳 𝗡𝗶𝗴𝗲𝗿𝗶𝗮’𝘀 𝗶𝗻𝘁𝗲𝗿𝗻𝗲𝘁 𝗲𝘅𝗰𝗵𝗮𝗻𝗴𝗲 𝗴𝗿𝗼𝘄𝘁𝗵‎‎• ‎IXPN will...